Rectal cancer is a cancer deriving from abnormal cell growth in the lining or epithelium of the rectum. Rectal and colorectal tumours are genetically considered to be the same cancer. Rectal ...
Recent research from the S:CORT team has identified key biomarkers and treatment strategies that predict and enhance effectiveness of radiotherapy in rectal cancer treatment. Patients with ...
GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug development data. Attributes of the drug, ...
TILT-123 is under clinical development by TILT Biotherapeutics and currently in Phase I for Rectal Cancer. According to GlobalData, Phase I drugs for Rectal Cancer does not have sufficient historical ...